当前位置:主页 > 医学论文 > 五官科论文 >

视网膜静脉阻塞患者血小板参数及同型半胱氨酸水平的临床分析

发布时间:2019-02-13 09:31
【摘要】:目的检测视网膜静脉阻塞(retinal vein occlusion,RVO)患者的同型半胱氨酸(homocysteine,Hcy)水平和血小板参数,包括血小板计数(platelet,PLT)、血小板平均体积(mean platelet volume,MPV),探讨两者是否作为致病因素参与RVO发病。方法对临床诊断为RVO的48例患者(RVO组)进行血PLT、MPV、Hcy测定,包括视网膜分支静脉阻塞(branch retinal vein occlusion,BRVO)患者22例(BRVO组)和视网膜中央静脉阻塞(central retinal vein occlusion,CRVO)患者26例(CRVO组),并与临床诊断为白内障的40例对照组进行比较并作统计学分析。结果 RVO组PLT水平(212.99±50.10)×10~9L~(-1),与对照组PLT水平(198.11±44.69)×10~9L~(-1)比较,差异无统计学意义(P0.05),RVO组MPV与Hcy水平(9.44±0.97)f L、(8.99±0.81)μmol·L~(-1)较对照组(8.66±0.96)f L和(8.38±0.62)μmol·L~(-1)均增高(均为P0.05)。PLT水平在CRVO组(212.27±49.07)×10~9L~(-1)、BRVO组(213.84±52.43)×10~9L~(-1)及对照组间比较差异均无统计学意义(均为P0.05),MPV、Hcy水平在CRVO组(9.48±0.91)f L、(8.97±0.76)μmol·L~(-1)与BRVO组(9.40±1.06)f L、(9.01±0.89)μmol·L~(-1),较对照组均增高(均为P0.05),但在CRVO组与BRVO组间比较差异均无统计学意义(均为P0.05)。结论高MPV、高Hcy可能是引起RVO发病的危险因素,降血小板及降Hcy的治疗从理论上讲是一种积极有效的预防措施。
[Abstract]:Objective to detect the levels of homocysteine (homocysteine,Hcy) and platelet parameters, including platelet count (platelet,PLT) and mean platelet volume (mean platelet volume,MPV) in patients with retinal vein occlusion (retinal vein occlusion,RVO). To explore whether the two factors play a role in the pathogenesis of RVO. Methods Blood PLT,MPV,Hcy was measured in 48 patients with RVO (RVO group), including 22 patients with retinal branch vein occlusion (branch retinal vein occlusion,BRVO) and (central retinal vein occlusion, with central retinal vein occlusion (BRVO group). 26 cases of CRVO (CRVO group) were compared with 40 cases of control group. Results the level of PLT in RVO group was (212.99 卤50.10) 脳 10 ~ (-9) L ~ (-1), and the level of PLT was (198.11 卤44.69) 脳 10 ~ (9) L ~ (-1) in RVO group. There was no significant difference (P0.05) between MPV and Hcy in), RVO group (9.44 卤0.97) f L,). The level of (8.99 卤0.81) 渭 mol L ~ (-1) in CRVO group was significantly higher than that in control group (8.66 卤0.96) f L and (8.38 卤0.62) 渭 mol L ~ (-1) (P0.05). PLT) in CRVO group (212.27 卤49.07) 脳 10 ~ (9) L ~ (-1). There was no significant difference between BRVO group (213.84 卤52.43) 脳 10 ~ (9) L ~ (-1) and control group (P0.05), and MPV,Hcy level was (9.48 卤0.91) f L, in CRVO group. (8.97 卤0.76) 渭 mol L ~ (-1) and BRVO (9.40 卤1.06) f L, (9.01 卤0.89) 渭 mol L ~ (-1), which were higher than those in the control group (P0.05). But there was no significant difference between CRVO group and BRVO group (P0.05). Conclusion High MPV, and high Hcy may be the risk factors of RVO. The treatment of decreasing platelet and decreasing Hcy is an active and effective preventive measure in theory.
【作者单位】: 锦州医科大学;锦州医科大学附属第一医院眼科;
【分类号】:R774.1

【相似文献】

相关期刊论文 前10条

1 肖屏风;中西医结合治疗视网膜静脉阻塞24例[J];湖南中医杂志;2000年03期

2 吴健梅;中西医结合治疗视网膜静脉阻塞27例[J];河南中医;2000年05期

3 卢宁,李志辉;视网膜静脉阻塞治疗新方法的实验和临床研究[J];国外医学.眼科学分册;2001年02期

4 万素萍;中西医结合治疗视网膜静脉阻塞29例[J];湖南中医杂志;2002年05期

5 钱志成,黄彩英;中西医药辨治视网膜静脉阻塞[J];天津药学;2002年06期

6 于俊利,赵志凛;两种不同方法治疗视网膜静脉阻塞疗效分析[J];临床眼科杂志;2003年01期

7 张晓湄,何剑峰;视网膜静脉阻塞的研究进展[J];临床眼科杂志;2003年02期

8 程慧君,詹宇坚;视网膜静脉阻塞的疗效及机理研究进展[J];中国中医眼科杂志;2003年04期

9 周平,区显宁,周卫为;氪激光治疗视网膜静脉阻塞的疗效评估[J];眼科新进展;2004年01期

10 孟根花,乌仁图雅;视网膜静脉阻塞的治疗进展[J];内蒙古医学杂志;2004年08期

相关会议论文 前10条

1 陈宝军;;76例视网膜静脉阻塞临床治疗观察[A];浙江省中医药学会眼科分会2009继续教育学习班论文集[C];2009年

2 姜虎林;杨雪萍;王淑静;韩旭巍;杨超;;中西医结合治疗视网膜静脉阻塞临床观察[A];第六届全国中医中西医结合眼科学术交流会论文汇编[C];2007年

3 刘艳红;申梨花;廖珊;王s阒,

本文编号:2421405


资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/wuguanyixuelunwen/2421405.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户92a6e***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com